Delivery Order SPE2DB22D3301-SPE2DB25FY6CC
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,134.25 firm fixed-price Delivery Order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 6, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a total ceiling value of $1,036.29 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 26, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is not...
This federal contract award is for the delivery of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,161.80 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 17, 2024 with a completion date of October 18, 2024. The contract is a Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,786.07 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,702.34 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through the DLA's Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The IDC serves as a primary vehicle for providing a range of pharmaceutical products and medical supplies to support military...
This federal contract award is for the delivery of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,113.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a Delivery Order with a Firm Fixed Price of $1,267.14 and an Ultimate...
This federal contract award is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 31, 2025, with a ceiling value of $2,789.97 and a final completion date of February 3, 2025. The contract is a delivery order with a firm fixed-price pricing type. The award is not designated as a set-aside contract,...
This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $3,111.61. The contract has a completion date of July 16, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,646.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, to the DLA. The contract has an ultimate completion date of December 5, 2024, and is a Firm Fixed Price Delivery Order. This contract award is not associated with a set-aside program....